TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · IEX Real-Time Price · USD
8.68
-0.13 (-1.48%)
May 7, 2024, 2:18 PM EDT - Market open
TScan Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$11.33
Upside
+30.53%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +15.21% | Apr 23, 2024 |
| Barclays | Barclays | Buy Maintains $7 → $9 | Buy | Maintains | $7 → $9 | +3.69% | Mar 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +72.81% | Mar 7, 2024 |
| Wedbush | Wedbush | Buy Reiterates $9 | Buy | Reiterates | $9 | +3.69% | Feb 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +72.81% | Aug 14, 2023 |
| Wedbush | Wedbush | Buy Initiates $8 | Buy | Initiates | $8 | -7.83% | Jun 22, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +72.81% | May 18, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +72.81% | May 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +72.81% | Mar 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $15 | Strong Buy | Maintains | $21 → $15 | +72.81% | May 10, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 16, 2021 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 13, 2021 |
| Morgan Stanley | Morgan Stanley | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 10, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Aug 10, 2021 |